Atlas Trials

Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus

Clinical trial NCT07441187 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07441187
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2026-02-20
Primary completion
2027-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.